XL3

XL3 is an over-the-counter (OTC) multi-symptom combination medication developed and marketed by Genomma Lab Internacional for the symptomatic relief of the common cold and influenza. The product line includes several formulations, most notably a combination of acetaminophen (analgesic/antipyretic), phenylephrine hydrochloride (nasal decongestant), and chlorpheniramine maleate (antihistamine). This combination effectively addresses fever, minor aches, nasal congestion, and allergic symptoms like sneezing. Additionally, the XL3 VR (antiviral) variant incorporates amantadine, which acts as an M2 proton channel inhibitor to provide specific activity against seasonal Influenza A. XL3 is a prominent consumer health brand in Latin American markets and is also available in the United States.

Brand names

XL3XL-3XL 3XL3 VRXL-3 VRXL 3 VR